Virax Biolabs Group Limited (NASDAQ:VRAX) Short Interest Update

Virax Biolabs Group Limited (NASDAQ:VRAX) saw a significant growth in short interest during the month of August. As of August 15th, there was short interest totaling 40,900 shares, agrowthof176.4% from the July 31st total of 14,800 shares. Based on an average trading volume of 453,200 shares, the short-interest ratio is presently 0.1 days. Approximately1.1% of the shares of the stock are short sold. Approximately1.1% of the shares of the stock are short sold. Based on an average trading volume of 453,200 shares, the short-interest ratio is presently 0.1 days.

Virax Biolabs Group Stock Performance

VRAX opened at $0.57 on Friday. Virax Biolabs Group has a 1-year low of $0.52 and a 1-year high of $4.26. The firm has a 50-day moving average price of $0.81 and a two-hundred day moving average price of $1.01.

Virax Biolabs Group Company Profile

Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid tests, and neutralizing antibody tests under the ViraxClear brand name.